Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93

Scott Wadler, Donna E. Levy, Sarah T. Lincoln, Gamini S. Soori, Julian C. Schink, Gary Goldberg

Research output: Contribution to journalArticle

37 Scopus citations

Fingerprint Dive into the research topics of 'Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93'. Together they form a unique fingerprint.

Medicine & Life Sciences